Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies
Two-stage model infers transcriptome from breast cancer histopathology to predict neoadjuvant therapy response, reaching pooled AUROC 0.79 across nine cohorts.